{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:47:58Z","timestamp":1794325678396,"version":"4.9.0"},"reference-count":48,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"12","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Neoplasms involving plasmacytoid dendritic cells (pDC) include blastic pDC neoplasms (BPDCN) and other pDC proliferations, where pDC are associated with myeloid malignancies: most frequently chronic myelomonocytic leukemia (CMML) but also acute myeloid leukemia (AML), hereafter named pDC-AML. We aimed to determine the reactive or neoplastic origin of pDC in pDC-AML, and their link with the CD34+ blasts, monocytes or conventional DC (cDC) associated in the same sample, by phenotypic and molecular analyses (targeted next-generation sequencing, 70 genes). We compared 15 pDCAML at diagnosis with 21 BPDCN and 11 normal pDC from healthy donors. CD45low CD34+ blasts were found in all cases (10-80% of medullar cells), associated with pDC (4-36%), monocytes in 14 cases (1-10%) and cDC (two cases, 4.8-19%). pDC in pDC-AML harbor a clearly different phenotype from BPDCN: CD4+ CD56\u2013 in 100% of cases, most frequently CD303+, CD304+ and CD34+; lower expression of cTCL1 and CD123 with isolated lymphoid markers (CD22\/CD7\/CD5) in some cases, suggesting a prepDC stage. In all cases, pDC, monocytes and cDC are neoplastic since they harbor the same mutations as CD34+ blasts. RUNX1 is the most commonly mutated gene: detected in all AML with minimal differentiation (M0-AML) but not in the other cases. Despite the low number of cases, the systematic association between M0-AML, RUNX1 mutations and an excess of pDC is puzzling. Further evaluation in a larger cohort is required to confirm RUNX1 mutations in pDC-AML with minimal differentiation and to investigate whether it represents a proliferation of blasts with macrophage and DC progenitor potential.<\/jats:p>","DOI":"10.3324\/haematol.2020.253740","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T08:39:10Z","timestamp":1602578350000},"page":"3056-3066","source":"Crossref","is-referenced-by-count":78,"title":["Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape"],"prefix":"10.3324","volume":"106","author":[{"given":"Loria","family":"Zalma\u00ef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Julien","family":"Viailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabeha","family":"Biichle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meyling","family":"Cheok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lou","family":"Soret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Angelot-Delettre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Agn\u00e8s","family":"Collonge-Rame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Seilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Geffroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Deconinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Daguindau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bouyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Dindinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Baunin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Le Garff-Tavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Roos-Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orianne","family":"Wagner-Ballon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Salaun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Feuillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Drenou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mayeur-Rousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Okamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Dorvaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Tichionni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Th\u00e9r\u00e8se","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Christine","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Raggueneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Preudhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Saas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Ferrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Adotevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Roumier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Jardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Garnache-Ottou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Renosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"31713","doi-asserted-by":"crossref","unstructured":"Banchereau J, Briere F, Caux C. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18767-811.","DOI":"10.1146\/annurev.immunol.18.1.767"},{"key":"31714","doi-asserted-by":"crossref","unstructured":"Jegalian AG, Facchetti F, Jaffe ES. Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol. 2009; 16(6):392-404.","DOI":"10.1097\/PAP.0b013e3181bb6bc2"},{"key":"31715","doi-asserted-by":"crossref","unstructured":"Naik SH, Sathe P, Park H-Y. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol. 2007; 8(11):1217-1226.","DOI":"10.1038\/ni1522"},{"key":"31716","doi-asserted-by":"crossref","unstructured":"Onai N, Obata-Onai A, Schmid MA, Ohteki T, Jarrossay D, Manz MG. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol. 2007; 8(11):1207-1216.","DOI":"10.1038\/ni1518"},{"key":"31717","doi-asserted-by":"crossref","unstructured":"Chaperot L, Bendriss N, Manches O. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood. 2001; 97(10):3210-3217.","DOI":"10.1182\/blood.V97.10.3210"},{"key":"31718","doi-asserted-by":"crossref","unstructured":"Garnache-Ottou F, Feuillard J, Ferrand C. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol. 2009; 145(5):624-636.","DOI":"10.1111\/j.1365-2141.2009.07679.x"},{"key":"31719","doi-asserted-by":"crossref","unstructured":"Facchetti F, Cigognetti M, Fisogni S, Rossi G, Lonardi S, Vermi W. Neoplasms derived from plasmacytoid dendritic cells. Mod Pathol. 2016; 29(2):98-111.","DOI":"10.1038\/modpathol.2015.145"},{"key":"31720","unstructured":"Swerdlow SH, Campo E, Harris NL. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th Edition. 2017."},{"key":"31721","doi-asserted-by":"crossref","unstructured":"Petrella T, Comeau MR, Maynadi\u00e9 M. \u201cAgranular CD4+ CD56+ hematodermic neoplasm\u201d (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002; 26(7):852-862.","DOI":"10.1097\/00000478-200207000-00003"},{"key":"31722","doi-asserted-by":"crossref","unstructured":"Petrella T, Facchetti F. Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009?. Autoimmunity. 2010; 43(3):210-214.","DOI":"10.3109\/08916930903510898"},{"key":"31723","doi-asserted-by":"crossref","unstructured":"Vitte F, Fabiani B, B\u00e9net C. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases. Am J Surg Pathol. 2012; 36(9):1302-1316.","DOI":"10.1097\/PAS.0b013e31825dd4de"},{"key":"31724","doi-asserted-by":"crossref","unstructured":"Dargent J-L, Delannoy A, Pieron P, Husson B, Debecker C, Petrella T. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm. J Cutan Pathol. 2011; 38(11):893-898.","DOI":"10.1111\/j.1600-0560.2011.01777.x"},{"key":"31725","doi-asserted-by":"crossref","unstructured":"Orazi A, Chiu R, O\u2019Malley DP. Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology. Mod Pathol. 2006; 19(12):1536-1545.","DOI":"10.1038\/modpathol.3800707"},{"key":"31726","doi-asserted-by":"crossref","unstructured":"Hamadeh F, Awadallah A, Meyerson HJ, Beck RC. Flow cytometry identifies a spectrum of maturation in myeloid neoplasms having plasmacytoid dendritic cell differentiation. Cytometry B Clin Cytom. 2020; 98(1):43-51.","DOI":"10.1002\/cyto.b.21761"},{"key":"31727","doi-asserted-by":"crossref","unstructured":"Huang Y, Wang Y, Chang Y. Myeloid neoplasms with elevated plasmacytoid dendritic cell differentiation reflect the maturation process of dendritic cells. Cytom A. 2020; 97(1):61-69.","DOI":"10.1002\/cyto.a.23953"},{"key":"31728","unstructured":"Wang P, Feng Y, Deng X. Tumor-forming plasmacytoid dendritic cells in acute myelocytic leukemia: a report of three cases and literature review. Int J Clin Exp Pathol. 2017; 10(7):7285-7291."},{"key":"31729","doi-asserted-by":"crossref","unstructured":"Xiao W, Goldberg AD, Famulare C. Acute myeloid leukemia with plasmacytoid dendritic cell differentiation: predominantly Secondary AML, enriched for RUNX1 mutations, frequent cross-lineage antigen expression and poor prognosis. Blood. 2018; 132(Suppl 1):S2789.","DOI":"10.1182\/blood-2018-99-119081"},{"key":"31730","doi-asserted-by":"crossref","unstructured":"Bodmer A, Menter T, Juskevicius D. Sharing of a PTPN11 mutation by myelodysplastic bone marrow and a mature plasmacytoid dendritic cell proliferation provides evidence for their common myelomonocytic origin. Virchows Arch. 2017; 470(4):469-473.","DOI":"10.1007\/s00428-017-2075-5"},{"key":"31731","doi-asserted-by":"crossref","unstructured":"Horny HP, Feller AC, Horst HA, Lennert K. Immunocytology of plasmacytoid T cells: marker analysis indicates a unique phenotype of this enigmatic cell. Hum Pathol. 1987; 18(1):28-32.","DOI":"10.1016\/S0046-8177(87)80189-2"},{"key":"31732","doi-asserted-by":"crossref","unstructured":"Angelot-Delettre F, Biichle S, Ferrand C. Intracytoplasmic detection of TCL1--but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis. Cytom A. 2012; 81(8):718-724.","DOI":"10.1002\/cyto.a.22072"},{"key":"31733","doi-asserted-by":"crossref","unstructured":"Vermi W, Facchetti F, Rosati S. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol. 2004; 28(5):585-595.","DOI":"10.1097\/00000478-200405000-00004"},{"key":"31734","doi-asserted-by":"crossref","unstructured":"Rickmann M, Krauter J, Stamer K. Elevated frequencies of leukemic myeloid and plasmacytoid dendritic cells in acute myeloid leukemia with the FLT3 internal tandem duplication. Ann Hematol. 2011; 90(9):1047-1058.","DOI":"10.1007\/s00277-011-1231-2"},{"key":"31735","doi-asserted-by":"crossref","unstructured":"Mohty M, Jarrossay D, Lafage-Pochitaloff M. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood. 2001; 98(13):3750-3756.","DOI":"10.1182\/blood.V98.13.3750"},{"key":"31736","doi-asserted-by":"crossref","unstructured":"Lucas N, Duchmann M, Rameau P. Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia. Leukemia. 2019; 33(10):2466-2480.","DOI":"10.1038\/s41375-019-0447-3"},{"key":"31737","unstructured":"Viailly P-J, Mareschal S, Bertrand P. GenerateReports: an Ion Torrent plugin summarizing a whole NGS experiment for clinical interpretation. 2015."},{"key":"31738","doi-asserted-by":"crossref","unstructured":"Wang W, Khoury JD, Miranda RN. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10- color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm. Haematologica. 2021; 106(4):1047-1055.","DOI":"10.3324\/haematol.2020.247569"},{"key":"31739","doi-asserted-by":"crossref","unstructured":"Xiao W, Goldberg AD, Famulare CA. Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia. Haematologica. 2019; 104(7):1378-1387.","DOI":"10.3324\/haematol.2018.203018"},{"key":"31740","doi-asserted-by":"crossref","unstructured":"Comeau MR, Van der Vuurst de Vries A-R, Maliszewski CR, Galibert L. CD123bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion?. J Immunol. 1950. 2002; 169(1):75-83.","DOI":"10.4049\/jimmunol.169.1.75"},{"key":"31741","doi-asserted-by":"crossref","unstructured":"MacDonald KPA, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DNJ. Characterization of human blood dendritic cell subsets. Blood. 2002; 100(13):4512-4520.","DOI":"10.1182\/blood-2001-11-0097"},{"key":"31742","doi-asserted-by":"crossref","unstructured":"Feuillard J, Jacob M-C, Valensi F. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood. 2002; 99(5):1556-1563.","DOI":"10.1182\/blood.V99.5.1556"},{"key":"31743","doi-asserted-by":"crossref","unstructured":"Garnache-Ottou F, Vidal C, Biichl\u00e9 S. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?. Blood Adv. 2019; 3(24):4238-4251.","DOI":"10.1182\/bloodadvances.2019000647"},{"key":"31744","doi-asserted-by":"crossref","unstructured":"Julia F, Dalle S, Duru G. Blastic plasmacytoid dendritic cell neoplasms: clinicoimmunohistochemical correlations in a series of 91 patients. Am J Surg Pathol. 2014; 38(5):673-680.","DOI":"10.1097\/PAS.0000000000000156"},{"key":"31745","unstructured":"Lamar E, Roggy A, Le Calvez G. Blastic plasmacytoid dendritic cell neoplasm: report of a case with atypical cytology and immunophenotype. J Blood Disord. 2015; 2(3):1033."},{"key":"31746","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Mart\u00edn L, Almeida J, Hern\u00e1ndez-Campo PM, S\u00e1nchez ML, L\u00e9crevisse Q, Orfao A. Immunophenotypical, morphologic, and functional characterization of maturation- associated plasmacytoid dendritic cell subsets in normal adult human bone marrow. Transfusion. 2009; 49(8):1692-1708.","DOI":"10.1111\/j.1537-2995.2009.02170.x"},{"key":"31747","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Mart\u00edn L, L\u00f3pez A, Vidriales B. Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile. Oncotarget. 2015; 6(22):19204-19216.","DOI":"10.18632\/oncotarget.4146"},{"key":"31748","doi-asserted-by":"crossref","unstructured":"Tsagarakis NJ, Kentrou NA, Papadimitriou KA. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group. Leuk Res. 2010; 34(4):438-446.","DOI":"10.1016\/j.leukres.2009.09.006"},{"key":"31749","doi-asserted-by":"crossref","unstructured":"Mani R, Goswami S, Gopalakrishnan B. The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia\/myelodysplastic syndrome patients and healthy donors. Haematologica. 2018; 103(8):1288-1297.","DOI":"10.3324\/haematol.2018.188193"},{"key":"31750","doi-asserted-by":"crossref","unstructured":"Kovtun Y, Jones GE, Adams S. A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells. Blood Adv. 2018; 2(8):848-858.","DOI":"10.1182\/bloodadvances.2018017517"},{"key":"31751","doi-asserted-by":"crossref","unstructured":"Mardiros A, Dos Santos C, McDonald T. T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia. Blood. 2013; 122(18):3138-3148.","DOI":"10.1182\/blood-2012-12-474056"},{"key":"31752","doi-asserted-by":"crossref","unstructured":"Pemmaraju N, Lane AA, Sweet KL. Tagraxofusp in blastic plasmacytoid dendritic- cell neoplasm. N Engl J Med. 2019; 380(17):1628-1637.","DOI":"10.1056\/NEJMoa1815105"},{"key":"31753","doi-asserted-by":"crossref","unstructured":"Villani A-C, Satija R, Reynolds G. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017; 356(6335):eaah4573.","DOI":"10.1126\/science.aah4573"},{"key":"31754","doi-asserted-by":"crossref","unstructured":"Gaidzik VI, Teleanu V, Papaemmanuil E. RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico- pathologic and genetic features. Leukemia. 2016; 30(11):2282.","DOI":"10.1038\/leu.2016.207"},{"key":"31755","doi-asserted-by":"crossref","unstructured":"Roumier C, Eclache V, Imbert M. M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Fran\u00e7ais d\u2019H\u00e9matologie Cellulaire (GFHC) and the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH). Blood. 2003; 101(4):1277-1283.","DOI":"10.1182\/blood-2002-05-1474"},{"key":"31756","doi-asserted-by":"crossref","unstructured":"Menezes J, Acquadro F, Wiseman M. Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm. Leukemia. 2014; 28(4):823-829.","DOI":"10.1038\/leu.2013.283"},{"key":"31757","doi-asserted-by":"crossref","unstructured":"Antony-Debr\u00e9 I, Duployez N, Bucci M. Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia. Leukemia. 2016; 30(4):999-1002.","DOI":"10.1038\/leu.2015.236"},{"key":"31758","doi-asserted-by":"crossref","unstructured":"Morita K, Suzuki K, Maeda S. Genetic regulation of the RUNX transcription factor family has antitumor effects. J Clin Invest. 2017; 127(7):2815-2828.","DOI":"10.1172\/JCI91788"},{"key":"31759","doi-asserted-by":"crossref","unstructured":"Kubota S, Tokunaga K, Umezu T. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm. Nat Commun. 2019; 10(1):1653.","DOI":"10.1038\/s41467-019-09710-z"},{"key":"31760","doi-asserted-by":"crossref","unstructured":"Chopin M, Preston SP, Lun ATL. RUNX2 mediates plasmacytoid dendritic cell egress from the bone marrow and controls viral immunity. Cell Rep. 2016; 15(4):866-878.","DOI":"10.1016\/j.celrep.2016.03.066"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2020.253740\/72470","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2020.253740\/73876","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10047\/72470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:58:21Z","timestamp":1794045501000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2020.253740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2020.253740","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}